Vertex Pharmaceuticals
VRTX
#191
Rank
HK$949.59 B
Marketcap
HK$3,741
Share price
-0.95%
Change (1 day)
4.33%
Change (1 year)

EPS for Vertex Pharmaceuticals (VRTX)

EPS in 2026 (TTM): HK$132.87

According to Vertex Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$133.39. In 2025 the company made an earnings per share (EPS) of HK$121.32 an increase over its 2024 EPS that were of -HK$16.15.

EPS history for Vertex Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$132.879.52%
2025HK$121.32-850.97%
2024-HK$16.15-114.67%
2023HK$110.108.17%
2022HK$101.7942.64%
2021HK$71.36-12.67%
2020HK$81.71128.01%
2019HK$35.84-44.54%
2018HK$64.62670.09%
2017HK$8.39-327.66%
2016-HK$3.69-79.65%
2015-HK$18.12-26.43%
2014-HK$24.6253.92%
2013-HK$16.00316.33%
2012-HK$3.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.50-48.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.13-87.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$58.19-56.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$28.03-78.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$27.92-79.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-HK$20.31-115.23%๐Ÿ‡บ๐Ÿ‡ธ USA